Polpharma Biologics

Polpharma Biologics is a biopharmaceutical company headquartered in Switzerland that develops, manufactures and commercializes biosimilars for global markets. We manage the entire value chain: from product selection and investment allocation, through program execution to asset monetization, ensuring fast progress from idea to launch. Our international team of senior experts has proven experience in program leadership, regulatory strategy, clinical oversight, CMC integration, device development and quality. Working with trusted CDMOs, we deliver end-to-end biosimilars, from cell line to finished product, across a range of major therapeutic areas. Our commercial partners bring these medicines to patients worldwide. Our mission is simple: to accelerate access to biologics. To fulfill that mission, we maintain a robust, expanding pipeline of biosimilars in development.